RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 23-33
  • J&J beats forecasts, helped by new hepatitis C drug

    (Reuters) - Johnson & Johnson reported higher-than-expected quarterly results on sizzling sales of its new Olysio treatment for hepatitis C, but company officials cautioned the pill will lose steam later this year as newer rivals come to market. Global...
  • Drugmaker Valeant touts Bausch + Lomb growth to Allergan investors

    (Reuters) - Valeant Pharmaceuticals Inc moved on Friday to blunt a key criticism by takeover target Allergan Inc of its Bausch + Lomb business by releasing data showing strong sales growth. Allergan, which is trying to fend off a $51 billion hostile...
  • Abbott to sell generics in major markets to Mylan for $5.3 billion

    Abbott to sell generics in major markets to Mylan for $5.3 billion
    Abbott Laboratories has agreed to sell its specialty and branded generic pharmaceutical business in developed markets to Pennsylvania-based Mylan Inc. in an all-stock transaction valued at about $5.3 billion. The deal, which will give Abbott a roughly...
  • Shire confirms in talks with AbbVie on takeover bid

    Shire confirms in talks with AbbVie on takeover bid
    Shire Plc on Friday confirmed it has held a meeting with U.S. drugmaker AbbVie Inc to discuss AbbVie's takeover bid for the Dublin-based maker of drugs for rare diseases. Shire, in a release, said it would provide a further update "when appropriate." It...
  • AbbVie forced to retract claims of Shire investor support

    AbbVie forced to retract claims of Shire investor support
    AbbVie Inc. CEO Richard Gonzalez has landed in a bit of hot water for statements he made to certain newswires and U.K. press on Tuesday regarding shareholder support for his company's takeover bid for Shire Plc. The North Chicago-based pharmaceutical...
  • AbbVie to buy drugmaker Shire in nearly $55 billion deal

    AbbVie to buy drugmaker Shire in nearly $55 billion deal
    AbbVie Inc. has inked a nearly $55 billion deal to acquire drugmaker Shire PLC, the companies announced in a joint statement Friday morning. The deal, the largest of a year filled with merger and acquisition activity, will allow the North Chicago-...
  • Shire, AbbVie to announce $53 billion merger by Friday: sources

    Shire, AbbVie to announce $53 billion merger by Friday: sources
    (Reuters) - Shire Plc and U.S. drugmaker Abbvie Inc plan to announce a $53 billion merger as soon as Friday morning, two people said on Thursday. Dublin-based Shire, which sells drugs for rare diseases, said earlier this week it was ready to recommend...
  • FedEx indicted on charges of shipping drugs for illegal online pharmacies

    SAN FRANCISCO FedEX has been indicted by a federal grand jury on charges of shipping powerful prescription drugs for illegal online pharmacies, the latest major company targeted by federal law enforcement for playing a part in the proliferation of such...
  • Baxter has no plans for inversion with spinoff

     Baxter has no plans for inversion with spinoff
    While its peers in the northern suburbs and around the pharmaceutical industry have been lining up foreign mergers to help sidestep U.S. taxes, Baxter International said Thursday it has no plans to jump on the bandwagon. The Deerfield-based health...
  • AbbVie to Buy Shire for $54.8 billion in biggest inversion

    AbbVie to Buy Shire for $54.8 billion in biggest inversion
    AbbVie Inc. is buying Shire for nearly $55 billion, the largest deal in a year filled with merger and acquisition activity, and the latest example of companies taking foreign addresses to cut taxes. The deal will allow North Chicago-based pharmaceutical...
  • Pill look different? Shape and color changes may prompt lapses

    Pill look different? Shape and color changes may prompt lapses
    In a decade, Americans have saved an estimated $1.2 trillion by taking generic drugs instead of the high-priced originals. But the booming market in copycat prescription pharmaceuticals - coupled with insurance companies' efforts to keep healthcare...